May 2019 PMID 31288917

Antidepressant Withdrawal and Rebound Phenomena.

Jonathan Henssler, Andreas Heinz, Lasse Brandt, Tom Bschor

Download social card

Mentions

Peak: 3 in Jul 2022

across 5 sources since Jul 2019

Extended reach

157,458

potential audience

Total likes

2,123

Video views

149,084

Mentions per month

Jul 2019 – Oct 2025

Where it's discussed

News10 articles
Instagram7 posts
YouTube2 videos
X / Twitter1 posts
Facebook1 posts

AI synopsis

What people are saying

The collective responses show acknowledgment of the article's significance, with comments on the fact that withdrawal symptoms are usually mild but can be severe depending on the medication, and the importance of gradual discontinuation. The tone suggests that the publication could have a meaningful impact on how physicians approach antidepressant withdrawal, as seen in phrases like 'important for physicians to understand' and 'minimize withdrawal effects.'

AgreementModerate agreement

The posts generally agree on the importance of understanding withdrawal and rebound effects in antidepressant discontinuation, emphasizing the need for careful management.

InterestModerate interest

There is moderate interest in the topic, with discussions reflecting curiosity about how withdrawal symptoms are handled and the risks involved.

EngagementModerate engagement

Posts engage with the content by referencing specific points like gradual discontinuation and severity of symptoms, indicating a thoughtful discussion.

ImpactModerate impact

The discussions highlight the potential influence of the publication on clinical practices and patient awareness, suggesting it could lead to more cautious prescribing and discontinuing behaviors.

Abstract in brief

Antidepressants are widely used and often discontinued without medical guidance, making it important for physicians to understand withdrawal and rebound effects.
Most withdrawal symptoms are mild and temporary, such as dizziness, sleep issues, and mood swings, but some medications like MAO inhibitors and certain antidepressants pose higher risks of severe symptoms.
Discontinuing antidepressants gradually over at least four weeks is recommended to minimize withdrawal and rebound phenomena, although rebound effects like increased relapse rates require further research.

Read the full abstract

All mentions

Understanding Antidepressant Withdrawal Syndrome Effects and Guidelines

In today's video, we will discuss the significant impacts of antidepressant withdrawal syndrome. A systematic review reveals incidence rates of withdrawal symptoms between 27% to 86%, contradicting existing guidelines…

Levelheaded Mind · Jul 18, 2022 145,368 views

Understanding Antidepressants and Addiction: Facts and Neurobiology

This video discusses the controversy around antidepressants and addiction, explaining the difference between addiction and neuroadaptation, and the neurobiological processes involved in dependence and withdrawal. Learn…

Levelheaded Mind · Jul 25, 2022 3,716 views

小嶋慎二＠community pharmacist

@kojima_aponet · X

Antidepressant Withdrawal and Rebound Phenomena https://t.co/NONBw30CL6 via @dt_aerzteblatt

Jul 9, 2019 · 8,195 followers View post →

Dtsch Arztebl Int 2019; 116: 355-61; DOI: 10.3238/arztebl.2019.0355. Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. /RFBSIP, stockadobecom.

News

Dtsch Arztebl Int 2019; 116: 355-61; DOI: 10.3238/arztebl.2019.0355. Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. /RFBSIP, stockadobecom.

Dec 13, 2025 View →

Antidepressants & Psychedelics Guide | PDF | Antidepressant ...

News

Arztebl Int. 2019;116(20):355-361. doi:10.3238/arztebl.2019.0355 8. Cosci F, Chouinard G. Acute and Persistent Withdrawal Syndromes Following ...

Dec 13, 2025 View →

Dtsch Arztebl Int 2019; 116: 355-61; DOI: 10.3238/arztebl.2019.0355. Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. /Sebastian Kaulitzki ...

News

Dtsch Arztebl Int 2019; 116: 355-61; DOI: 10.3238/arztebl.2019.0355. Henssler, Jonathan; Heinz, Andreas; Brandt, Lasse; Bschor, Tom. /Sebastian Kaulitzki ...

Dec 13, 2025 View →

Stopping Antidepressant Medication Risks and Benefits

News

doi:10.3238/arztebl.2019.0355. Horowitz MA, Taylor D. Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant ...

Dec 13, 2025 View →

Clinical Depression An Individualized, Biopsychosocial Approach ...

News

... 10.3238/arztebl.2019.0355. Hersen, M., & Thomas, J. C. (2007). Handbook of clinical interviewing with adults. Sage Publications. https://doi.org/10.4135 ...

Dec 13, 2025 View →

Psychiatrie und Psychotherapie – Fachgebiete – Deutsches Ärzteblatt

News

Hintergrund: Die schlafbezogenen Erkrankungen stellen eine Krankheitsgruppe mit hoher Auswirkung auf die Lebensqualität und … Abbildung der Print-Seite.

Dec 13, 2025 View →

Absetz- und Rebound-Phänomene bei Antidepressiva – Deutsches ...

News

Dtsch Arztebl Int 2019; 116: 355–61. DOI: 10.3238/arztebl.2019.0355. ▻Die englische Version des Artikels ist online abrufbar unter: www.aerzteblatt ...

Dec 13, 2025 View →

Projeto Tarja Preta | UFPB | Vamos conversar sobre dependência e ...

Instagram

... 10.3238/arztebl.2019.0355. HOROWITZ, M. A.; TAYLOR, D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, v ...

Oct 6, 2025 View →

Projeto Tarja Preta | UFPB | Você já ouviu falar em tristeza sazonal ...

Instagram

DOI: 10.3238/arztebl.2019.0355. HOROWITZ, M. A.; TAYLOR, D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet ...

Sep 9, 2025 View →